World-first laboratory study finds low-dose Naltrexone may improve ME/CFS symptoms Griffith Health PublishedJuly 14, 2021August 17, 2022 AuthorDeborah Marshall Low-dose Naltrexone may reduce Myalgic Encephalomyelitis/Chronic Fatigue Syndrome symptoms study finds.
NHMRC grant boosts ME/CFS research Disability and Rehabilitation PublishedOctober 7, 2020October 9, 2020 AuthorDeborah Marshall NHMRC funding will pave the way for diagnostic tools and therapies for ME/CFS.
ME/CFS economic cost: $14.5B each year Griffith Health PublishedSeptember 3, 2020September 3, 2020 AuthorEddie Ngaluafe Griffith University research has calculated the cost of the debilitating illness ME/CFS for the first time in Australia.